![Jayant Vaidya: UK patients prefer receiving TARGIT-IORT while they are asleep during surgery](https://oncodaily.com/pub/uploads/2024/09/jayant-e1725475311604.jpg)
Photo of Jayant Vaidya taken from ucl.ac.uk
Sep 6, 2024, 10:50
Jayant Vaidya: UK patients prefer receiving TARGIT-IORT while they are asleep during surgery
Jayant Vaidya, Professor of Surgery and Oncology,
“UK patients with breast cancer perceive even 5-day post-op radiotherapy as being greatly disruptive. They prefer receiving TARGIT-IORT while they are asleep during surgery – it gives them the feeling of stamping out the cancer without conscious awareness.”
Source: Jayant Vaidya/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023